ArticleCancer research and treatment2015

Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors.

Do-Youn Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.